Skip to main content
Article
Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment
Journal for ImmunoTherapy of Cancer (2015)
  • Robert Hi Andtbacka, Huntsman Cancer Institute
  • Brendan D Curti, Providence Portland Medical Center
  • Sigrun Hallmeyer, Oncology Specialsists, Park Ridge, USA
  • Zipei Feng, Earle A. Chiles Research Institute, Portland, USA
  • Christopher Paustian, Chiles Research Institute, Providence Cancer Center, Portland, USA
  • Carlo Bifulco, Providence Cancer Center, Earle A. Chiles Research Institute, Portland, USA
  • Bernard Fox, Earle A. Chiles Research Institute, Portland, USA
  • Mark Grose, Viralytics Limited, Toronto, Canada
  • Darren Shafren, Viralytics, Sydney, Australia
Publication Date
November 4, 2015
DOI
10.1186/2051-1426-3-S2-P343
Citation Information
Robert Hi Andtbacka, Brendan D Curti, Sigrun Hallmeyer, Zipei Feng, et al.. "Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment" Journal for ImmunoTherapy of Cancer Vol. 3 Iss. 2 (2015) p. 343
Available at: http://works.bepress.com/carlo-bifulco/97/